TF and neoplasm: Saini and Bandyopadhyaya designed transferrin (Tf)-conjugated, chitosan-coated mesoporous silica nanoparticles (MSNs) loaded with the anticancer drug gemcitabine.82 They demonstrated that the nanoparticles release the drug at a very low rate in a neutral environment, but in a large amount in the tumor environment.